At a glance
- Originator Nonindustrial source
- Class Antivirals; Stilbenes
- Mechanism of Action HIV envelope protein gp120 inhibitors; HIV fusion inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 11 Jun 2001 No-Development-Reported for HIV infections treatment in USA (Unknown route)
- 16 Sep 1997 New profile
- 16 Sep 1997 Preclinical development for HIV infections treatment in USA (Unknown route)